Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $25.76 million.

GUIDANCE:

Foundation Medicine sees Q1 2016 revenue of $110-120 million, versus the consensus of $115.6 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.